Cardiac Rhythm Management Devices Market will be Valued at A CAGR OF 4.8% Globally by 2023 - ABBOTT, ABIOMED, BIOTRONIK SE & CO KG, BOSTON SCIENTIFIC CORPORATION, KONINKLIJKE PHILIPS NV, LIVANOVA, MEDTRONIC

The global cardiac rhythm management devices market is expected to register a CAGR of 4.8% during the forecast period, 2018 - 2023. Cardiac rhythm management is a part of electrophysiology, which is used to manage the functioning of the heart. With well-established healthcare infrastructure, favorable reimbursement schemes, and higher healthcare expenditure, North America is expected to dominate the market.

Detailed Sample Copy of Updated Analysis @ https://www.marketprognosis.com/sample-request/16953
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Major players:
ABBOTT, ABIOMED, BIOTRONIK SE & CO KG, BOSTON SCIENTIFIC CORPORATION, KONINKLIJKE PHILIPS NV, LIVANOVA PLC, MEDTRONIC PLC, SCHILLER AG, SHENZHEN MINDRAY BIOMEDICAL ELECTRONICS CO., LTD, AND ZOLL MEDICAL CORPORATION, amongst others.

Rising Prevalence of Cardiovascular Disorders
The increasing instances of cardiovascular disorders is one of the foremost factors driving the cardiac rhythm management devices market. Globally, cardiovascular diseases account for more than 30% deaths, amounting to 17 million people. Also, nearly 33.5 million people, globally, are suffering from atrial fibrillation (AFib), which is the most common type of serious arrhythmia. With the rise in the aging population in America and Europe, a number of patients suffering heart rhythm disorders are likely to witness an increase, and this is a cause for concern.
The technological advancement in cardiology, increase in the use of ambulatory and home services for cardiac monitoring, and favorable reimbursement policies are other factors that are driving this market.

Get Quality Discount @ https://www.marketprognosis.com/discount-request/16953
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Effects of Therapeutic Radiation on Implantable Cardiac Rhythm Devices
The therapeutic radiation used in cancer treatment can influence the operation of a patient with implantable cardiac rhythm devices. The implantable device technology uses complementary metal-oxide semiconductor (CMOS) which are vulnerable to damage by the therapeutic doses of radiation, but it can vary according to the type of device in use. This factor is one of the major factors that limits the scope of using cardiac rhythm management devices, as the implants are highly sensitive and their malfunctioning may have serious consequences. Another major factor limiting the growth of this market is the high cost of these devices with limited insurance coverage.

The United States to Have Largest Market Share
North America is expected to have the largest market share for cardiac rhythm management, due to developed healthcare infrastructure, government initiatives, rising number of death due to cardiovascular diseases, and rising incidence of arrhythmias demanding more cardiac implants. According to a report by the US CDC, more than 75,000 hospitalizations are attributed atrial fibrillation. Also, it highlighted that a large part of the American population suffers from atrial fibrillation. Therefore, it is expected to rise further in the forecast period. Asia-Pacific is another region with high potential for this market, due to rising healthcare expenditure by government, increasing the prevalence of cardiac disorders, and growing per capita income of population in South Asian countries.

Browse Report @ https://www.marketprognosis.com/enquiry/16953
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

About Market Prognosis

We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:

ProgMarkPvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.